Health Catalyst Inc (2YP.SG)
| Previous Close | 5.90 |
| Open | 6.05 |
| Bid | 6.15 x N/A |
| Ask | 6.25 x N/A |
| Day's Range | 6.05 - 6.05 |
| 52 Week Range | 5.10 - 12.90 |
| Volume | |
| Avg. Volume | 0 |
| Market Cap | N/A |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | Aug 06, 2024 - Aug 12, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
GlobeNewswireHealth Catalyst to Participate in Upcoming Investor Conferences
SALT LAKE CITY, May 30, 2024 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Jason Alger, Chief Financial Officer, and Jack Knight, Vice President of Investor Relations, will participate in the following upcoming investor conferences: The Stifel Cross Sector Insight Conference, being held in Boston, including a fireside chat on Tuesday, June 4, 2024, at
ZacksZacks Industry Outlook Highlights Hims & Hers Health, Enovis Corp and Health Catalyst
Hims & Hers Health, Enovis Corp and Health Catalyst are part of the Zacks Industry Outlook article.
StockStoryData Analytics Stocks Q1 Teardown: Domo (NASDAQ:DOMO) Vs The Rest
As the Q1 earnings season comes to a close, it’s time to take stock of this quarter's best and worst performers in the data analytics industry, including Domo (NASDAQ:DOMO) and its peers.
